![]() |
| Liquid Chromatography Mass Spectrometry |
The
Liquid Chromatography Mass Spectrometry (LCMS) Market is estimated to be valued
at US$ 5.15 billion in 2022 and is
expected to exhibit a CAGR of 9.4%
over the forecast period 2023-2030,
as highlighted in a new report published by Coherent Market Insights.
Market Overview:-
LCMS
combines the separation capabilities of liquid chromatography with the mass
analysis capabilities of mass spectrometry. It allows the identification of
different compounds based on their mass-to-charge ratios.
Market Dynamics:-
The
growing demand for effective analytical tools in pharma research and
development is a key driver boosting the LCMS market. LCMS has emerged as a
widely used technique for drug discovery, development, and quality control. It
enables characterization of complex biological samples involved in the pharma
R&D process. Furthermore, increasing applications of LCMS in proteomics and
metabolomics research are also contributing to market growth. The rise of
personalized medicine has further accelerated the need for sensitive detection
of metabolites and peptides, propelling the demand for LCMS.
Market key trends:-
The
Liquid Chromatography Mass Spectrometry (LCMS) market has been witnessing
rising adoption of triple quadrupole mass spectrometers. Triple quadrupole mass
spectrometers are widely used for quantitative analysis offering high
specificity and sensitivity. They provide accurate detection and quantification
of target compounds from complex mixtures. Further, there has been a growing
demand for high resolution accurate mass spectrometers (HRAM) such as Q
Exactive which help in identifying unknown compounds and metabolites with
higher specificity.
SWOT Analysis:-
·
Strength: LCMS technologies offer high
selectivity and sensitivity for analysis of various compounds from complex
mixtures in less time.
·
Weakness: LCMS instruments have high
initial costs and require trained professionals for operation and maintenance.
·
Opportunity: Increasing R&D
investments in pharmaceutical and biotechnology industries and growth in
clinical testing labs present opportunity for market players.
·
Threats: Presence of cheaper
substitutes such as gas chromatography mass spectrometry (GCMS) and lack of
skilled professionals pose threats.
Key Takeaways:-
The Global
Liquid Chromatography Mass Spectrometry (LCMS) Market Growth is
expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period, due to increasing demand from
pharmaceutical and clinical research. In 2022, the market size was valued at US$ 5.15 billion.
Regional
analysis: North America dominated the global market in 2022 owing to presence
of many pharmaceutical companies and clinical research organizations in the US
and Canada. Asia Pacific is anticipated to witness fastest growth due to rising
pharmaceutical outsourcing in countries such as India and China along with
growing biotechnology sector.
Key
players analysis: Key players operating in the LCMS market are Danaher
Corporation, PerkinElmer, Inc., Waters Corporation, Bruker Corporation, Thermo
Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation, JEOL
Ltd., and Newomics, Inc. Danaher Corporation dominated the market with its
broad product portfolio. Waters Corporation offers Synapt G2 high definition
mass spectrometry system with advanced ion mobility.

Comments
Post a Comment